Helical TomoTherapy in the treatment of central nervous system metastasis.

Joseph M. Baisden, Stanley H Benedict, K. Sheng, Paul W. Read, James M. Larner

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In this report the authors review the use of radiotherapy in the treatment of central nervous system (CNS) metastasis. They comment on different treatment methods for both intracranial and extracranial CNS metastasis and discuss some of the evidence supporting the use of radiotherapy in these settings. Recent advancements in radiation oncology technology are briefly reviewed with a focus on the advantages and disadvantages of helical TomoTherapy-based treatment strategies. A review of pertinent current literature was performed. TomoTherapy research currently underway at the University of Virginia Health System is discussed and a representative case is presented. Radiotherapy for CNS metastasis is an effective treatment that provides palliation of symptoms and confers a survival advantage on selected patients. Advances in radiotherapy techniques continue to improve the therapeutic ratio for patients with CNS metastases. Helical TomoTherapy offers distinct advantages for patients with CNS metastatic disease by sparing normal tissue when intracranial or extracranial disease is targeted.

Original languageEnglish (US)
JournalNeurosurgical Focus
Volume22
Issue number3
StatePublished - 2007
Externally publishedYes

Fingerprint

Intensity-Modulated Radiotherapy
Central Nervous System
Neoplasm Metastasis
Radiotherapy
Therapeutics
Radiation Oncology
Central Nervous System Diseases
Technology
Survival
Health
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Baisden, J. M., Benedict, S. H., Sheng, K., Read, P. W., & Larner, J. M. (2007). Helical TomoTherapy in the treatment of central nervous system metastasis. Neurosurgical Focus, 22(3).

Helical TomoTherapy in the treatment of central nervous system metastasis. / Baisden, Joseph M.; Benedict, Stanley H; Sheng, K.; Read, Paul W.; Larner, James M.

In: Neurosurgical Focus, Vol. 22, No. 3, 2007.

Research output: Contribution to journalArticle

Baisden, JM, Benedict, SH, Sheng, K, Read, PW & Larner, JM 2007, 'Helical TomoTherapy in the treatment of central nervous system metastasis.', Neurosurgical Focus, vol. 22, no. 3.
Baisden, Joseph M. ; Benedict, Stanley H ; Sheng, K. ; Read, Paul W. ; Larner, James M. / Helical TomoTherapy in the treatment of central nervous system metastasis. In: Neurosurgical Focus. 2007 ; Vol. 22, No. 3.
@article{9278cde09d844a45912095f7d1173c92,
title = "Helical TomoTherapy in the treatment of central nervous system metastasis.",
abstract = "In this report the authors review the use of radiotherapy in the treatment of central nervous system (CNS) metastasis. They comment on different treatment methods for both intracranial and extracranial CNS metastasis and discuss some of the evidence supporting the use of radiotherapy in these settings. Recent advancements in radiation oncology technology are briefly reviewed with a focus on the advantages and disadvantages of helical TomoTherapy-based treatment strategies. A review of pertinent current literature was performed. TomoTherapy research currently underway at the University of Virginia Health System is discussed and a representative case is presented. Radiotherapy for CNS metastasis is an effective treatment that provides palliation of symptoms and confers a survival advantage on selected patients. Advances in radiotherapy techniques continue to improve the therapeutic ratio for patients with CNS metastases. Helical TomoTherapy offers distinct advantages for patients with CNS metastatic disease by sparing normal tissue when intracranial or extracranial disease is targeted.",
author = "Baisden, {Joseph M.} and Benedict, {Stanley H} and K. Sheng and Read, {Paul W.} and Larner, {James M.}",
year = "2007",
language = "English (US)",
volume = "22",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Helical TomoTherapy in the treatment of central nervous system metastasis.

AU - Baisden, Joseph M.

AU - Benedict, Stanley H

AU - Sheng, K.

AU - Read, Paul W.

AU - Larner, James M.

PY - 2007

Y1 - 2007

N2 - In this report the authors review the use of radiotherapy in the treatment of central nervous system (CNS) metastasis. They comment on different treatment methods for both intracranial and extracranial CNS metastasis and discuss some of the evidence supporting the use of radiotherapy in these settings. Recent advancements in radiation oncology technology are briefly reviewed with a focus on the advantages and disadvantages of helical TomoTherapy-based treatment strategies. A review of pertinent current literature was performed. TomoTherapy research currently underway at the University of Virginia Health System is discussed and a representative case is presented. Radiotherapy for CNS metastasis is an effective treatment that provides palliation of symptoms and confers a survival advantage on selected patients. Advances in radiotherapy techniques continue to improve the therapeutic ratio for patients with CNS metastases. Helical TomoTherapy offers distinct advantages for patients with CNS metastatic disease by sparing normal tissue when intracranial or extracranial disease is targeted.

AB - In this report the authors review the use of radiotherapy in the treatment of central nervous system (CNS) metastasis. They comment on different treatment methods for both intracranial and extracranial CNS metastasis and discuss some of the evidence supporting the use of radiotherapy in these settings. Recent advancements in radiation oncology technology are briefly reviewed with a focus on the advantages and disadvantages of helical TomoTherapy-based treatment strategies. A review of pertinent current literature was performed. TomoTherapy research currently underway at the University of Virginia Health System is discussed and a representative case is presented. Radiotherapy for CNS metastasis is an effective treatment that provides palliation of symptoms and confers a survival advantage on selected patients. Advances in radiotherapy techniques continue to improve the therapeutic ratio for patients with CNS metastases. Helical TomoTherapy offers distinct advantages for patients with CNS metastatic disease by sparing normal tissue when intracranial or extracranial disease is targeted.

UR - http://www.scopus.com/inward/record.url?scp=34547670989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547670989&partnerID=8YFLogxK

M3 - Article

C2 - 17608361

AN - SCOPUS:34547670989

VL - 22

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 3

ER -